These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

419 related items for PubMed ID: 9916747

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Genetic variability of hepatitis C virus non-structural protein 3 and virus-specific CD8+ response in patients with chronic hepatitis C.
    López-Labrador FX, He XS, Berenguer M, Cheung RC, González-Candelas F, Wright TL, Greenberg HB.
    J Med Virol; 2004 Apr; 72(4):575-85. PubMed ID: 14981760
    [Abstract] [Full Text] [Related]

  • 4. Identification of hepatitis C virus (HCV) 2a-derived epitope peptides having the capacity to induce cytotoxic T lymphocytes in human leukocyte antigen-A24+ and HCV2a-infected patients.
    Wang Y, Takao Y, Harada M, Komatsu N, Ono T, Sata M, Itoh K, Yamada A.
    Cell Immunol; 2006 May; 241(1):38-46. PubMed ID: 16963008
    [Abstract] [Full Text] [Related]

  • 5. HLA A2 restricted cytotoxic T lymphocyte responses to multiple hepatitis B surface antigen epitopes during hepatitis B virus infection.
    Nayersina R, Fowler P, Guilhot S, Missale G, Cerny A, Schlicht HJ, Vitiello A, Chesnut R, Person JL, Redeker AG, Chisari FV.
    J Immunol; 1993 May 15; 150(10):4659-71. PubMed ID: 7683326
    [Abstract] [Full Text] [Related]

  • 6. Identification of HLA-A*3101-restricted cytotoxic T-lymphocyte response to human immunodeficiency virus type 1 (HIV-1) in patients with chronic HIV-1 infection.
    Borghan MA, Oka S, Takiguchi M.
    Tissue Antigens; 2005 Oct 15; 66(4):305-13. PubMed ID: 16185326
    [Abstract] [Full Text] [Related]

  • 7. Identification of HLA-A3-restricted cytotoxic T lymphocyte epitopes from carcinoembryonic antigen and HER-2/neu by primary in vitro immunization with peptide-pulsed dendritic cells.
    Kawashima I, Tsai V, Southwood S, Takesako K, Sette A, Celis E.
    Cancer Res; 1999 Jan 15; 59(2):431-5. PubMed ID: 9927058
    [Abstract] [Full Text] [Related]

  • 8. Cytotoxic T lymphocyte response and viral load in hepatitis C virus infection.
    Hiroishi K, Kita H, Kojima M, Okamoto H, Moriyama T, Kaneko T, Ishikawa T, Ohnishi S, Aikawa T, Tanaka N, Yazaki Y, Mitamura K, Imawari M.
    Hepatology; 1997 Mar 15; 25(3):705-12. PubMed ID: 9049223
    [Abstract] [Full Text] [Related]

  • 9. CTL responses of HLA-A2.1-transgenic mice specific for hepatitis C viral peptides predict epitopes for CTL of humans carrying HLA-A2.1.
    Shirai M, Arichi T, Nishioka M, Nomura T, Ikeda K, Kawanishi K, Engelhard VH, Feinstone SM, Berzofsky JA.
    J Immunol; 1995 Mar 15; 154(6):2733-42. PubMed ID: 7533182
    [Abstract] [Full Text] [Related]

  • 10. Identification of immunodominant hepatitis C virus (HCV)-specific cytotoxic T-cell epitopes by stimulation with endogenously synthesized HCV antigens.
    Urbani S, Uggeri J, Matsuura Y, Miyamura T, Penna A, Boni C, Ferrari C.
    Hepatology; 2001 Jun 15; 33(6):1533-43. PubMed ID: 11391544
    [Abstract] [Full Text] [Related]

  • 11. Use of two predictive algorithms of the world wide web for the identification of tumor-reactive T-cell epitopes.
    Lu J, Celis E.
    Cancer Res; 2000 Sep 15; 60(18):5223-7. PubMed ID: 11016651
    [Abstract] [Full Text] [Related]

  • 12. [A HLA-A2-restricted-CTL epitope variation at the N-terminal of HCV helicase and the immune response of CTLs].
    Guo HZ, Wang WL, Wang T.
    Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2004 May 15; 20(3):325-7. PubMed ID: 15193229
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Liver-derived CTL in hepatitis C virus infection: breadth and specificity of responses in a cohort of persons with chronic infection.
    Wong DK, Dudley DD, Afdhal NH, Dienstag J, Rice CM, Wang L, Houghton M, Walker BD, Koziel MJ.
    J Immunol; 1998 Feb 01; 160(3):1479-88. PubMed ID: 9570570
    [Abstract] [Full Text] [Related]

  • 16. Analysis of the CD8-positive T cell response in Japanese patients with chronic hepatitis C using HLA-A*2402 peptide tetramers.
    Nakamoto Y, Kaneko S, Takizawa H, Kikumoto Y, Takano M, Himeda Y, Kobayashi K.
    J Med Virol; 2003 May 01; 70(1):51-61. PubMed ID: 12629644
    [Abstract] [Full Text] [Related]

  • 17. Genetic immunization and comprehensive screening approaches in HLA-A2 transgenic mice lead to the identification of three novel epitopes in hepatitis C virus NS3 antigen.
    Martin P, Parroche P, Chatel L, Barretto C, Beck A, Trépo C, Bain C, Lone YC, Inchauspé G, Fournillier A.
    J Med Virol; 2004 Nov 01; 74(3):397-405. PubMed ID: 15368525
    [Abstract] [Full Text] [Related]

  • 18. Mapping HLA-A2, -A3 and -B7 supertype-restricted T-cell epitopes in the ebolavirus proteome.
    Lim WC, Khan AM.
    BMC Genomics; 2018 Jan 19; 19(Suppl 1):42. PubMed ID: 29363421
    [Abstract] [Full Text] [Related]

  • 19. Conserved hepatitis C virus sequences are highly immunogenic for CD4(+) T cells: implications for vaccine development.
    Lamonaca V, Missale G, Urbani S, Pilli M, Boni C, Mori C, Sette A, Massari M, Southwood S, Bertoni R, Valli A, Fiaccadori F, Ferrari C.
    Hepatology; 1999 Oct 19; 30(4):1088-98. PubMed ID: 10498664
    [Abstract] [Full Text] [Related]

  • 20. A peptide derived from hepatitis C virus (HCV) core protein inducing cellular responses in patients with HCV with various HLA class IA alleles.
    Niu Y, Komatsu N, Komohara Y, Matsueda S, Yutani S, Ishihara Y, Itou M, Yamada A, Itoh K, Shichijo S.
    J Med Virol; 2009 Jul 19; 81(7):1232-40. PubMed ID: 19475615
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 21.